Report of the workshop on nasal and related extranodal angiocentric T/natural killer cell lymphomas: Definitions, differential diagnosis, and epidemiology

American Journal of Surgical Pathology

Volumn 20, Issue 1, 1996, Pages 103-111

  Jaffe, Elaine S ^a   Chan, John K C ^b   Su, Ih Jen ^c   Frizzera, Glauco ^d   Mori, Shigeo ^e   Feller, A C ^f   Ho, Faith C S ^g  

^a NATIONAL CANCER INSTITUTE   (United States)

^b QUEEN ELIZABETH HOSPITAL   (Hong Kong)

^c NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^d NEW YORK UNIVERSITY MEDICAL CENTER   (United States)

^e UNIVERSITY OF TOKYO   (Japan)

^f UNIVERSITY OF LÜBECK   (Germany)

^g UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

Angiocentric lymphoma; Epstein Barr virus; Lethal midline granuloma; Nasal lymphoma; Natural killer cells; T cell lymphoma

Indexed keywords

CD2 ANTIGEN; CD3 ANTIGEN; CD56 ANTIGEN;

CANCER INVASION; CONFERENCE PAPER; DIFFERENTIAL DIAGNOSIS; EPSTEIN BARR VIRUS; GENE REARRANGEMENT; HUMAN; HUMAN TISSUE; NATURAL KILLER CELL; NOSE TUMOR; PHENOTYPE; T CELL LYMPHOMA; TISSUE NECROSIS; TUMOR LOCALIZATION; TUMOR VASCULARIZATION;

DIAGNOSIS, DIFFERENTIAL; HUMANS; KILLER CELLS; LYMPHOMA; LYMPHOMA, T-CELL; NOSE NEOPLASMS; PROGNOSIS; TERMINOLOGY;

EID: 0029671295     PISSN: 01475185     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000478-199601000-00012     Document Type: Conference Paper

References (55)

1. Aozasa K, Ohsawa M, Tajima K, Sasaki R, Maeda H, Matsunaga T, Friedmann I. Nationwide study of lethal mid-line granuloma in Japan: frequencies of Wegener's granulomatosis, polymorphic reticulosis, malignant lymphoma and other related conditions. Int J Cancer 1989;44:63-6.
2. Aozasa K, Watanabe Y, Ikeda H. Malignant histiocytosis presenting as lethal midline granuloma. Pathol Res Pract 1981;171:314-24.
3. Arber DA, Weiss LM, Albujar PF, Chen YY, Jaffe ES. Nasal lymphomas in Peru, high incidence of T-cell immunophenotype and Epstein-Barr virus infection. Am J Surg Pathol 1993;17:392-9.
4. Borisch B, Hennig I, Laeng RH, Waelti ER, Kraft R, Laissue J. Association of the subtype 2 of the Epstein-Barr virus with T-cell non-Hodgkin's lymphoma of the midline granuloma type. Blood 1993;82:858-64.
5. Chan JKC, Ng CS, Lau WH, Lo STH. Most nasal/nasopharyngeal lymphomas are peripheral T-cell neoplasms. Am J Surg Pathol 1987;11:418-29.
6. Chan JKC, Ng CS, Tsang WYW. Nasal/nasopharyngeal lymphomas: an immunohistochemical analysis of 57 cases on frozen tissues [Abstract]. Mod Pathol 1993;6:87A.
7. Chan JKC, Sin VC, Ng CS, Lau WH. Cutaneous relapse of nasal T-cell lymphoma clinically mimicking erythema multiforme. Pathology 1989;21:164-8.
8. Chan JKC, Yip TTC, Tsang WYW, et al. Detection of Epstein-Barr viral RNA in malignant lymphomas of the upper aerodigestive tract. Am J Surg Pathol 1994;18:938-46.
9. Chott A, Rappersberger K, Schlossarek W, Radaszkiewicz T. Peripheral T cell lymphoma presenting primarily as lethal midline granuloma. Hum Pathol 1988;19:1093-101.
10. DeRemee RA, Weiland LH, McDonald TJ. Polymorphic reticulosis, lymphomatoid granulomatosis, two diseases or one? Mavo Clin Proc 1978;53:634-40.
11. Ferry J, Sklar J, Zukerberg L, Harris N. Nasal lymphoma: a clinicopathologic study with immunophenotypic and genotypic analysis. Am J Surg Pathol 1991;15:268-79.
12. Guinee D, Jaffe E, Kingma D, et al. Pulmonary lymphomatoid granulomatosis: evidence of Epstein-Barr virus infected B-lymphocytes with a predominant T-cell component and vasculitis. Am J Surg Pathol 1994;18:753-64.
13. Harabuchi Y, Yamanaka N, Kataura A, et al. Epstein-Barr virus in nasal T-cell lymphomas in patients with lethal midline granuloma. Lancet 1990;335:128-30.
14. Ho FCS, Choy D, Loke SL, et al. Polymorphic reticulosis and conventional lymphomas of the nose and upper aerodigestive tract: a clinicopathologic study of 70 cases, and immunophenotypic studies of 16 cases. Hum Pathol 1990;21: 1041-50.
15. Ho FCS, Srivastava G, Loke SL, et al. Presence of Epstein-Barr virus DNA in nasal lymphomas of B and T cell type. Hematol Oncol 1990;8:271-81.
16. Imamura N, Kisunoki Y, Kajihara H, Okada K, Kuramoto A. Aggressive natural killer cell leukemia/lymphoma with N901-positive surface phenotype: evidence for the existence of a third lineage in lymphoid cells. Acta Hematol 1988;80: 121-8.
17. Imamura N, Kusunoki Y, Kawaha K, et al. Aggressive natural killer cell leukemia/lymphoma: report of four cases and review of the literature. Br J Hematol 1990;75:49-59.
18. Isaacson P, Spencer J, Connolly C, et al. Malignant histiocytosis of the intestine: a T-cell lymphoma. Lancet 1985;2: 688-91.
19. Jaffe ES. Post-thymic T-cell lymphomas. In: Major problems in pathology: surgical pathology of the lymph nodes and related organs. vol 16. Philadelphia: WB Saunders, 1994:344-89.
20. Jaffe ES, Costa J, Fauci AS, et al. Malignant lymphoma and erythrophagocytosis simulating malignant histocytosis. Am J Med 1983;75:741-9.
21. Jaffe ES, Lipford EH, Margolick JB, Longo DL, Fauci AS. Lymphomatoid granulomatosis and angiocentric lymphoma: a spectrum of post-thymic T-cell proliferations. Semin Respir Med 1989;10:167-72.
22. Kanavaros P, Lescs MC, Briere J, et al. Nasal T-cell lymphoma: a clinicopathologic entity associated with peculiar phenotype and with Epstein-Barr virus. Blood 1993;81: 2688-95.
23. Kern WF, Spier CM, Hanneman EH, Miller TP, Matzner M, Grogan TM. Neural cell adhesion molecule-positive peripheral T-cell lymphoma: a rare variant with a propensity for unusual sites of involvement. Blood 1992;79:2432-7.
24. Kingma DW, Medeiros LJ, Roman LN, Jaffe ES. Expression of Epstein-Barr viral (EBV) EBER1 RNA in multifocal AIL of discordant histologic grades. Mod Pathol 1993;6: 94A.
25. Koss MN, Hochholzer L, Langloss JM, Wehunt WD, Lazarus AA, Nichols PW. Lymphomatoid granulomatosis: a clinicopathologic study of 42 patients. Pathology 1986;18: 283-8.
26. Lanier LL, Chang C, Spits H, Phillips JH. Expression of cytoplasmic CD3∈ proteins in activated human adult natural killer (NK) cells and CD3γ,δ,∈ complexes in fetal NK cells. J Immunol 1992;149:1876-80.
27. Liebow AA, Carrington CR, Friedman PJ. Lymphomatoid granulomatosis. Hum Pathol 1972;3:457-558.
28. Lin-Greenberg A, Villacin A, Moussa G. Lymphomatoid granulomatosis presenting as ulcerodestructive gastrointestinal tract lesions in patients with human immunodeficiency virus infection. A new association. Arch Intern Med 1990; 150:2581-3.
29. Lipford EH, Margolick JB, Longo DL, Fauci AS, Jaffe ES. Angiocentric immunoproliferative lesions: a clinicopathologic spectrum of post-thymic T-cell proliferations. Blood 1988;72:1674-81.
30. Lippman SM, Grogan TM, Spier CM, et al. Lethal midline granuloma with a novel T-cell phenotype as found in peripheral T-cell lymphoma. Cancer 1987;59:936-9.
31. Mroczek EC, Weisenburger DD, Grierson HL, Markin R, Purtilo DT. Fatal infectious mononucleosis and virusassociated hemophagocytic syndrome. Arch Pathol Lab Med 1984;111:530-5.
32. Medeiros LJ, Jaffe ES, Chen YY, Weiss LM. Localization of Epstein-Barr viral genomes in angiocentric immunoproliferative lesions. Am J Surg Pathol 1992;16:439-47.
33. Medeiros LJ, Peiper SC, Elwood L, Yano T, Raffeld M, Jaffe ES. Angiocentric immunoproliferative lesions: a molecular analysis of eight cases. Hum Pathol 1991;22:1150-7.
34. Myers J, Kurtin P, Katzenstein A-L, et al. Lymphomatoid granulomatosis: evidence of immunophenotypic diversity and relationship to Epstein-Barr virus infection [Abstract]. Mod Pathol 1995;8:150A.
35. Nakamura S, Suchi T, Koshikawa T, et al. Clinicopathologic study of CD56 (NCAM)-positive angiocentric lymphoma occurring in sites other than the upper and lower respiratory tract. Am J Surg Pathol 1995;19:284-96.
36. Navarro-Roman L, Zarate-Osorno A, Meneses A, Kingma DW, Jaffe ES. High grade AIL and Epstein-Barr virus infection in 22 cases from Mexico. Mod Pathol 1994;7:117A.
37. Ng CS, Chan JKC, Hui PK, Chan WC, Lo STH. Application of a T-cell receptor antibody βF1 for immunophenotypic analysis of malignant lymphomas. Am J Pathol 1988;132: 365-71.
38. Ng CS, Chan JKC, Lo STH. Expression of natural killer cell markers in non-Hodgkin's lymphomas. Hum Pathol 1987; 18:1257-62.
39. Phillips JH, Hori T, Nagler A, Bhat N, Spits H, Lanier LL. Ontogeny of human natural killer (NK) cells: fetal NK cells mediate cytolytic function and express cytoplasmic CD3∈,δ proteins. J Exp Med 1992;175:1055-66.
40. Scott AA, Head DR, Kopecky KJ, et al. HLA-DR-, CD33+, CD56+, CD16- myeloid/natural killer cell acute leukemia: a previously unrecognized form of acute leukemia potentially misdiagnosed as French-American-British acute myeloid leukemia-M3. Blood 1994;84:244-55.
41. Shneider B, Touloukian R, Hajjar F, Selsky C, Buckley P. Perianal ulceration. A novel manifestation of angiocentric lymphoma. Dig Dis Sci 1993;38:1162-6.
42. Simrell CR, Margolick JB, Crabtree GR, Cossman J, Fauci AS, Jaffe ES. Lymphokine-induced phagocytosis in angiocentric immunoproliferative lesions (AIL) and malignant lymphoma arising in AIL. Blood 1985;65:1469-76.
43. Soler J, Bordes R, Osrtuno F, et al. Aggressive natural killer cell leukemia/lymphoma in two patients with lethal midline granuloma. Br J Hematol 1994;86:659-62.
44. Su IJ, Hsieh HC. Clinicopathological spectrum of Epstein-Barr virus-associated T cell malignancies. Leuk Lymphoma 1992;7:47-53.
45. Su IJ, Hsieh HC, Lin KH, et al. Aggressive peripheral T-cell lymphomas containing Epstein-Barr viral DNA: a clinicopathologic and molecular analysis. Blood 1991;77:799-808.
46. Sullivan JL, Woda BA, Herrod HG, Koh G, Rivara FP, Mulder C. Epstein-Barr virus-associated hemophagocytic syndrome: Virological and immunopathological studies. Blood 1985;65:1097-104.
47. Sun T, Brody J, Susin M, et al. Aggressive natural killer cell lymphoma/leukemia: a recently recognized clinicopathologic entity. Am J Surg Pathol 1993;17:1289-99.
48. Suzumiya J, Takeshita M, Kimura N, et al. Sinonasal malignant lymphoma of natural killer cell phenotype associated with diffuse pancreatic involvement. Leuk Lymphoma 1993; 10:231-6.
49. Tao Q, Ho FCS, Loke SL, Srivastava G. Epstein-Barr virus is localized in the tumour cells of nasal lymphomas of NK, T or B cell type. Int J Cancer 1995;60:2-7.
50. Tsai TF, Su IJ, Lu YC, et al. Cutaneous angiocentric T-cell lymphoma associated with Epstein-Barr virus. J Am Acad Dermatol 1992;26:31-8.
51. Tsang WYW, Chan JKC, Yip TTC, et al. In-situ localization of Epstein-Barr virus RNA (EBER) in non-nasal/nasopharyngeal CD56-positive and CD56-negative T-cell lymphomas. Hum Pathol 1994;25:758-65.
52. van Gorp J, Liu WP, Jacobse K, et al. Epstein-Barr virus in nasal T-cell lymphomas (polymorphic reticulosis/midline malignant reticulosis) in Western China. J Pathol 1994;173: 81-7.
53. Weiss LM, Gaffey MJ, Chen YY, Frierson HF. Frequency of Epstein-Barr viral DNA in "Western" sinonasal and Waldeyer's ring non-Hodgkin's lymphomas. Am J Surg Pathol 1992;16:156-62.
54. Weiss LM, Picker LJ, Grogan TM, Warnke RA, Sklar J. Absence of clonal beta and gamma T-cell receptor gene rearrangements in a subset of peripheral T-cell lymphomas. Am J Pathol 1988;130:436-42.
55. Wong KF, Chan JKC, Ng CS, Lee KC, Tsang WYW, Cheung MMC. CD56 (NKH1)-positive hematolymphoid malignancies: an aggressive neoplasm featuring frequent cutaneous/mucosal involvement, cytoplasmic azurophilic granules and angiocentricity. Hum Pathol 1992;23:798-804.